Hangzhou
688767.SSHangzhou Biotest Biotech Co.,Ltd. Price (688767.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
106,605,812
(0.0571)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Hangzhou Biotest Biotech Co.,Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
121,770,765.00
+0% |
180,301,425.00
+48% |
208,842,040.00
+16% |
865,371,453.00
+314% |
1,818,075,902.00
+110% |
1,901,143,935.00
+5% |
442,110,404.00
-77% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 75,044,739.00 | 110,967,460.00 | 119,516,997.00 | 218,184,293.00 | 693,938,928.00 | 884,776,671.00 | 269,595,693.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
46,726,026.00
+0% |
69,333,965.00
+48% |
89,325,043.00
+29% |
647,187,160.00
+625% |
1,124,136,974.00
+74% |
1,016,367,264.00
-10% |
172,514,711.00
-83% |
||||||||||||
| Gross Profit Ratio | (0.38%) | (0.38%) | (0.43%) | (0.75%) | (0.62%) | (0.53%) | (0.39%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 10,852,233.00 | 9,667,052.00 | 16,845,401.00 | 41,324,148.00 | 61,924,538.00 | 108,208,922.00 | 80,475,253.00 | ||||||||||||
| General and Administrative | 7,206,623.00 | 7,360,814.00 | 10,196,953.00 | 9,403,274.00 | 19,916,653.00 | 25,460,832.00 | 20,433,580.00 | ||||||||||||
| Selling, General & Admin... | 20,367,721.00 | 23,377,339.00 | 28,740,559.00 | 47,878,952.00 | 42,829,456.00 | 53,926,755.00 | 31,482,381.00 | ||||||||||||
| Selling & Marketing Exp... | 13,161,097.00 | 16,016,525.00 | 18,543,606.00 | 38,475,678.00 | 22,912,803.00 | 28,465,922.00 | 11,048,801.00 | ||||||||||||
| Depreciation and Amortiz... | 3,362,293.00 | 4,159,300.00 | 4,948,800.00 | 5,587,500.00 | 10,632,611.00 | 23,330,640.00 | 29,277,607.00 | ||||||||||||
| Other Expenses | 15,328.00 | -13,319.80 | 8,612,579.00 | 19,862,496.00 | 37,298,662.00 | 34,164,983.00 | -56,266,597.00 | ||||||||||||
| Total Operating Expenses | 35,453,344.00 | 41,703,861.00 | 54,198,541.00 | 109,065,596.00 | 142,052,657.00 | 196,300,661.00 | 55,691,037.00 | ||||||||||||
| Cost and Exponses | 110,498,083.00 | 152,671,322.00 | 173,715,538.00 | 327,249,890.00 | 835,991,585.00 | 1,081,077,332.00 | 325,286,730.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
4,261,040.00
+0% |
22,546,889.00
+429% |
32,231,172.00
+43% |
513,082,581.00
+1,492% |
966,522,541.00
+88% |
914,343,239.00
-5% |
116,823,673.00
-87% |
||||||||||||
| Operating Income Ratio | (0.03%) | (0.13%) | (0.15%) | (0.59%) | (0.53%) | (0.48%) | (0.26%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 33,653.00 | 18,656.00 | 54,981.00 | 1,334,712.00 | 15,134,109.00 | 37,118,894.00 | 73,525,036.00 | ||||||||||||
| Interest Expenses | 629,491.00 | 966,575.00 | 862,502.00 | 467,113.00 | 678,067.00 | 194,483.00 | 838,552.00 | ||||||||||||
| Total Other Income/Exp... | 15,329.00 | -13,320.00 | 37,176.00 | 1,243,182.00 | 2,105,063.00 | -12,446,077.00 | -946,576.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 8,268,154.00 | 27,659,356.00 | 38,410,851.00 | 520,917,673.00 | 980,618,163.00 | 926,414,318.00 | 146,452,759.00 | ||||||||||||
| EBITDA ratio | (0.11%) | (0.19%) | (0.20%) | (0.61%) | (0.55%) | (0.52%) | (0.33%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 4,276,369.00 | 22,533,569.00 | 32,268,348.00 | 514,325,763.00 | 968,627,604.00 | 901,897,162.00 | 115,877,097.00 | ||||||||||||
| Income Before Tax Ratio | (0.04%) | (0.12%) | (0.15%) | (0.59%) | (0.53%) | (0.47%) | (0.26%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 921,008.00 | 3,680,674.00 | 4,333,029.00 | 79,359,450.00 | 132,871,684.00 | 128,313,107.00 | 10,577,296.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 4,031,157.00
+0% |
18,906,705.00
+369% |
28,228,431.00
+49% |
435,146,719.00
+1,442% |
833,590,633.00
+92% |
773,634,251.00
-7% |
106,605,811.00
-86% |
||||||||||||
| Net Income Ratio | (0.03%) | (0.10%) | (0.14%) | (0.50%) | (0.46%) | (0.41%) | (0.24%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.05 | 0.24 | 0.26 | 4.08 | 7.81 | 7.25 | 1.00 | ||||||||||||
| Diluted EPS | 0.05 | 0.24 | 0.26 | 4.08 | 7.81 | 7.25 | 1.00 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 80,623,144.00 | 78,777,941.00 | 106,666,667.00 | 106,666,667.00 | 106,666,667.00 | 106,666,667.00 | 106,605,812.00 | ||||||||||||
| Diluted Share Outstanding | 80,623,144.00 | 78,777,941.00 | 106,666,667.00 | 106,666,667.00 | 106,666,667.00 | 106,666,667.00 | 106,605,812.00 | ||||||||||||